SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-22-001134
Filing Date
2022-09-20
Accepted
2022-09-20 16:38:32
Documents
14
Period of Report
2022-09-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k-092022.htm   iXBRL 8-K 23844
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 11553
6 GRAPHIC image_001.jpg GRAPHIC 3169
  Complete submission text file 0001079973-22-001134.txt   216447

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE opgn-20220920.xsd EX-101.SCH 3218
4 XBRL LABEL FILE opgn-20220920_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE opgn-20220920_pre.xml EX-101.PRE 22353
8 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k-092022_htm.xml XML 3563
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 221254125
SIC: 8071 Services-Medical Laboratories
Industrial Applications and Services